Last updated: 2026-09-06 04:38:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Daxor Corporation (DXR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $10.43, with a market capitalization of $62.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.56 to $14.76. This page covers its latest market performance, valuation, price trends and company information.
$62.70M | |
$10.24 | |
$24.60 | |
$3.40 | |
$10.55 | |
6.79K | |
-- | |
-- | |
$14.76 | |
$8.56 | |
-- | |
-- |
Daxor Corporation (DXR) last closed at $10.55 as of 2026-09-04 20:05:00, unchanged from the previous close of $10.55.
During the latest regular trading session, DXR traded between $3.40 and $24.60, with a volume of 6.79K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Daxor Corporation (DXR) moved from $9.90 to $10.43, representing a gain of 5.30% ($0.52).
The stock traded between $10.18 and $10.80 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 19.45 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 30.1%
DXR is currently trading at $10.43, placing it 30.1% of the way from its 52-week low of $8.56 to its 52-week high of $14.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 750 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Daxor Corporation (DXR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.